Showing results (11-20 of 328) with videos related to
Sort By:
Pageof 33
Cancer Research|May 1, 1992
Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigenL Perey, D F Hayes, P Maimonis, et al.Cancer Research|May 19, 2001
Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibodyC Akewanlop, M Watanabe, B Singh, et al.Cancer Communications|January 1, 1989
Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell lineS R Hull, A Bright, K L Carraway, et al.Cancer Research|June 1, 1986
Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancerD F Hayes, M R Zalutsky, W Kaplan, et al.Oncogene|May 15, 2012
MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approachesD W KufeCancer|December 1, 1993
Localization of tumor-associated glycoprotein DF3 in normal, inflammatory, and neoplastic lesions of the colonC W Andrews, J M Jessup, H Goldman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1985
Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinomaH Sekine, D F Hayes, T Ohno, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1987
Identification of a family of high molecular weight tumor-associated glycoproteinsM Abe, D W KufeMolecular Pharmacology|July 1, 1984
Lethality associated with incorporation of 5-fluorouracil into preribosomal RNAD Herrick, D W KufeCancer Research|September 1, 1981
Synergistic effects with inhibitors of de novo pyrimidine synthesis, acivicin, and N-(phosphonacetyl)-L-aspartic acidE Loh, D W KufePageof 33